InVivo Therapeutics Holdings Operating Income 2010-2023 | NVIVQ

InVivo Therapeutics Holdings operating income from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
InVivo Therapeutics Holdings Annual Operating Income
(Millions of US $)
2022 $-11
2021 $-10
2020 $-9
2019 $-11
2018 $-13
2017 $-25
2016 $-24
2015 $-22
2014 $-18
2013 $-19
2012 $-13
2011 $-9
2010 $-3
2009 $-3
2009 $0
InVivo Therapeutics Holdings Quarterly Operating Income
(Millions of US $)
2023-09-30 $-3
2023-06-30 $-2
2023-03-31 $-2
2022-12-31 $-2
2022-09-30 $-3
2022-06-30 $-3
2022-03-31 $-3
2021-12-31 $-3
2021-09-30 $-2
2021-06-30 $-2
2021-03-31 $-2
2020-12-31 $-2
2020-09-30 $-2
2020-06-30 $-2
2020-03-31 $-2
2019-12-31 $-3
2019-09-30 $-3
2019-06-30 $-3
2019-03-31 $-3
2018-12-31 $-3
2018-09-30 $-2
2018-06-30 $-3
2018-03-31 $-5
2017-12-31 $-5
2017-09-30 $-6
2017-06-30 $-7
2017-03-31 $-7
2016-12-31 $-7
2016-09-30 $-6
2016-06-30 $-6
2016-03-31 $-6
2015-12-31 $-5
2015-09-30 $-6
2015-06-30 $-6
2015-03-31 $-6
2014-12-31 $-4
2014-09-30 $-4
2014-06-30 $-5
2014-03-31 $-5
2013-12-31 $-6
2013-09-30 $-5
2013-06-30 $-5
2013-03-31 $-3
2012-12-31 $-5
2012-09-30 $-3
2012-06-30 $-3
2012-03-31 $-2
2011-12-31 $-3
2011-09-30 $-2
2011-06-30 $-3
2011-03-31 $-1
2010-12-31 $-1
2010-09-30 $-1
2010-06-30 $-1
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.000B $0.000B
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.702B 27.74
Boston Scientific (BSX) United States $154.217B 38.61
Stryker (SYK) United States $145.561B 30.44
EssilorLuxottica (ESLOY) France $133.244B 0.00
Medtronic (MDT) Ireland $107.028B 15.63
Lonza Group Ag (LZAGY) Switzerland $52.631B 0.00
Haleon (HLN) United Kingdom $47.943B 27.26
ResMed (RMD) United States $35.287B 26.50
GE HealthCare Technologies (GEHC) United States $31.763B 15.08
Agilent Technologies (A) United States $30.897B 20.41
Terumo (TRUMY) Japan $29.152B 0.00
Koninklijke Philips (PHG) Netherlands $24.100B 17.21
Insulet (PODD) United States $18.209B 77.71
Zimmer Biomet Holdings (ZBH) United States $17.901B 11.50
Baxter (BAX) United States $15.608B 11.66
Smith & Nephew SNATS (SNN) United Kingdom $12.425B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $7.970B 0.00
Lantheus Holdings (LNTH) United States $7.395B 18.18
Bio-Rad Laboratories (BIO) United States $6.728B 22.75
Prestige Consumer Healthcare (PBH) United States $4.111B 19.62
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.444B 9.86
ICU Medical (ICUI) United States $3.347B 28.51
Haemonetics (HAE) United States $3.139B 14.77
Envista Holdings (NVST) United States $2.876B 23.90
GN Store Nord (GNNDY) Denmark $2.071B 17.15
QuidelOrtho (QDEL) United States $1.868B 15.64
LeMaitre Vascular (LMAT) United States $1.817B 40.63
AtriCure (ATRC) United States $1.439B 0.00
Green Thumb Industries (GTBIF) United States $1.359B 21.40
Neogen (NEOG) United States $1.224B 15.67
AdaptHealth (AHCO) United States $1.173B 11.30
Kestra Medical Technologies (KMTS) United States $1.159B 0.00
BioLife Solutions (BLFS) United States $1.150B 0.00
InMode (INMD) Israel $0.991B 9.08
Phibro Animal Health (PAHC) United States $0.791B 12.13
Evolus (EOLS) United States $0.774B 0.00
Owens & Minor (OMI) United States $0.632B 5.38
Curaleaf Holdings (CURLF) Canada $0.618B 0.00
CeriBell (CBLL) United States $0.583B 0.00
Valneva SE (VALN) France $0.557B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.539B 0.00
Capricor Therapeutics (CAPR) United States $0.470B 0.00
Tilray Brands (TLRY) Canada $0.442B 0.00
Cresco Labs (CRLBF) United States $0.437B 0.00
Omeros (OMER) United States $0.397B 0.00
Surmodics (SRDX) United States $0.386B 0.00
SNDL (SNDL) Canada $0.355B 0.00
VAREX IMAGING (VREX) United States $0.348B 15.09
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Verano Holdings (VRNOF) United States $0.312B 0.00
Viemed Healthcare (VMD) United States $0.290B 26.18
Sanara MedTech (SMTI) United States $0.288B 0.00
Aurora Cannabis (ACB) Canada $0.265B 47.20
Sanuwave Health (SNWV) United States $0.265B 0.00
Cerus (CERS) United States $0.249B 0.00
ZimVie (ZIMV) United States $0.247B 14.80
Canopy Growth (CGC) Canada $0.234B 0.00
Quanterix (QTRX) United States $0.225B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
High Tide (HITI) Canada $0.192B 0.00
Biote (BTMD) United States $0.178B 4.06
Utah Medical Products (UTMD) United States $0.172B 13.83
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
Brainsway (BWAY) Israel $0.164B 51.24
Organigram Global (OGI) Canada $0.149B 0.00
FitLife Brands (FTLF) United States $0.145B 17.91
Jin Medical (ZJYL) China $0.125B 0.00
TerrAscend (TSNDF) Canada $0.118B 0.00
Exagen (XGN) United States $0.113B 0.00
Agape ATP (ATPC) $0.105B 0.00
MacroGenics (MGNX) United States $0.103B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Quipt Home Medical (QIPT) United States $0.093B 0.00
Jushi Holdings (JUSHF) United States $0.081B 0.00
Fonar (FONR) United States $0.076B 10.61
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.064B 0.00
Cytosorbents (CTSO) United States $0.057B 0.00
United Health Products (UEEC) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Apyx Medical (APYX) United States $0.044B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Rockwell Medical (RMTI) United States $0.041B 59.50
Safety Shot (SHOT) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 11.31
Nephros (NEPH) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00